Zhenchuan Song, Ruoyang Li. "Eribulin plus pyrotinib In trastuzumab-resistant HER2-positive advanced breast cancer: A single-arm, multicenter phase II trial (EPIC trial).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1031